Literature DB >> 5547274

On thelipoprotein abnormality in type 3 hyperlipoproteinemia.

S Quarfordt, R I Levy, D S Fredrickson.   

Abstract

Two lipoprotein species were isolated by starch block electrophoresis from the very low density lipoproteins (VLDL) (S(f) 20-400) of patients with type III hyperlipoproteinemia. One of these, alpha(2)-VLDL, had a content of lipid and protein and physical characteristics similar to VLDL from normal subjects or patients with other forms of hyperglyceridemia. The other species, beta-VLDL, contained more cholesterol and less triglyceride in relation to the protein, than normal VLDL. Only the apoprotein of low density lipoprotein was immunochemically detectable in the beta-VLDL; the proteins in the alpha(2)-VLDL reacted with antisera specific for low density lipoprotein and high density lipoprotein. The electrophoretic mobility of beta-VLDL was similar to that of low density lipoprotein and significantly less than that of alpha(2)-VLDL. Isolated beta-VLDL had a lesser mean flotation rate than alpha(2)-VLDL, but both alpha(2)- and beta-VLDL were found throughout the S(f) 20-400 flotation range.The relative quantities of alpha(2)- and beta-VLDL could be varied by changing the diet or by heparin administration. Most of the VLDL from type III patients on a high carbohydrate diet was in the alpha(2)-VLDL form. During fasting, alpha(2)-VLDL fell and beta-VLDL increased becoming the predominant species of VLDL. Heparin-induced acceleration of triglyceride clearance also increased beta-VLDL and decreased alpha(2)-VLDL. These findings suggest a precursor-product relationship between the alpha(2)- and beta-forms of VLDL.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5547274      PMCID: PMC291989          DOI: 10.1172/JCI106546

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

Review 1.  Practical methods for plasma lipoprotein analysis.

Authors:  F T Hatch
Journal:  Adv Lipid Res       Date:  1968

2.  Analysis of change in ultracentrifugal lipoprotein profiles following heparin and ethyl-p-chlorophenoxyisobutyrate administration.

Authors:  A V Nichols; E H Strisower; F T Lindgren; G L Adamson; E L Coggiola
Journal:  Clin Chim Acta       Date:  1968-05       Impact factor: 3.786

3.  Very low density lipoprotein subfractions in a subject with broad-beta disease (Type 3 hyperlipoproteinemia) and a subject with endogenous lipemia (Type IV). Chemical composition and electrophoretic mobility.

Authors:  W R Hazzard; F T Lindgren; E L Bierman
Journal:  Biochim Biophys Acta       Date:  1970-05-05

Review 4.  The analysis of human serum lipoprotein distributions.

Authors:  A M Ewing; N K Freeman; F T Lindgren
Journal:  Adv Lipid Res       Date:  1965

Review 5.  Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

Authors:  D S Fredrickson; R I Levy; R S Lees
Journal:  N Engl J Med       Date:  1967-02-02       Impact factor: 91.245

6.  A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques.

Authors:  D S Fredrickson; R I Levy; F T Lindgren
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

7.  Particle size and protein content of six fractions of the Sf 20 plasma lipoproteins isolated by density gradient centrifugation.

Authors:  W J Lossow; F T Lindgren; J C Murchio; G R Stevens; L C Jensen
Journal:  J Lipid Res       Date:  1969-01       Impact factor: 5.922

8.  Lipoproteins--a current perspective of methods and concepts.

Authors:  J L Oncley; N R Harvie
Journal:  Proc Natl Acad Sci U S A       Date:  1969-11       Impact factor: 11.205

9.  The nature of pre beta (very low density) lipoproteins.

Authors:  R I Levy; R S Lees; D S Fredrickson
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

10.  Lipid abnormalities in foam cell reticulosis of mice, an analogue of human sphingomyelin lipidosis.

Authors:  D S Fredrickson; H R Sloan; C T Hansen
Journal:  J Lipid Res       Date:  1969-05       Impact factor: 5.922

View more
  14 in total

1.  Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat.

Authors:  O D Mjos; O Faergeman; R L Hamilton; R J Havel
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

2.  Evaluation of the classical methods for the diagnosis of type III hyperlipoproteinemia.

Authors:  J R Patsch; R L Jackson; A M Gotto
Journal:  Klin Wochenschr       Date:  1977-11-01

3.  [Type 3 hyperlipoproteinaemia (broad-beta disease): diagnosis and quantitative isolation of the typical lipoprotein (author's transl)].

Authors:  J R Patsch; S Sailer; W Patsch; H Braunsteiner
Journal:  Klin Wochenschr       Date:  1974-08-15

4.  Electron microscopy of low-density plasmalipoproteins in patients with type IIa hyperlipoproteinemia.

Authors:  B Agostini
Journal:  Naturwissenschaften       Date:  1973-02

5.  [Hyperlipoproteinemia and coronary disease. Occurrence, distribution of types, age and sex factors].

Authors:  U H Klemens; P von Löuis of Menar; A Bremer; E von Wnuck; R Schröder
Journal:  Klin Wochenschr       Date:  1972-02-01

6.  High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).

Authors:  D A Chappell
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  Liquid crystalline lipid in the plasma of humans with biliary obstruction.

Authors:  S H Quarfordt; H Oelschlaeger; W R Krigbaum
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

8.  Lipoprotein lipase in cholesterol-fed and control guinea pigs.

Authors:  F Sasinowski; R Ostwald
Journal:  Lipids       Date:  1981-05       Impact factor: 1.880

9.  Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins.

Authors:  R J Havel; J P Kane
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

10.  Mechanism of the hypolipemic effect of clofibrate in postabsorptive man.

Authors:  B M Wolfe; J P Kane; R J Havel; H P Brewster
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.